Top Markets
Coin of the day
Mabion S.A. Mabion S.A.

Mabion S.A.

MAB
Rankning i aktier #27004
Mabion S.A. is a Polish biopharmaceutical firm dedicated to pioneering the... Mabion S.A. is a Polish biopharmaceutical firm dedicated to pioneering the development of biological drugs, primarily leveraging monoclonal antibody technology. The company oversees the full spectrum from research and development to the manufacturing and commercialization of therapies designed to combat a wide range of diseases, including neoplastic (cancer), autoimmune, metabolic, and neurological disorders. Key products in its portfolio include MabionCD20 and MabionHER2. Established in 2007, Mabion S.A. maintains its headquarters in Konstantynów Lódzki, Poland.
Aktiekurs
$2.22
Marknadsvärde
$35.85M
Förändring (1 dag)
3.14%
Förändring (1 år)
-15.06%
Land
PL
Handel Mabion S.A. (MAB)

Kategori

Aktiekurshistorik för Mabion S.A. (MAB)
Högsta slutkurs: $2.13 den 2026-08-01

Lägsta slutkurs: $4.20 den 2010-08-01
Aktiekurshistorik för Mabion S.A. från 2010 till 2026
Årlig aktiekursutveckling
År Prestanda
2026 (TTM) 12.10%
2025 -19.31%
2024 -48.95%
2023 -2.07%
2022 -70.98%
2021 195.71%
2020 -72.42%
2019 -11.04%
2018 -20.35%
2017 62.87%
2016 57.30%
2015 6.33%
2014 -9.21%
2013 146.12%
2012 58.68%
2011 -42.39%
2010 0.00%
Aktiekurs för liknande företag eller konkurrenter
Företag Aktiekurs Förändring 1år% Land
$552.07 39.99%
US
$168.77 527.63%
US
$1.03K 56.22%
NL
$120.74 -14.98%
AU
$756.93 6.35%
CH